|Regado Biosciences, Inc.|
106 Allen Road
United States - Map
Regado Biosciences, Inc., a biopharmaceutical company, focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. The company was formerly known as Quartet Biosciences, Inc. and changed its name to Regado Biosciences, Inc. in March 2003. Regado Biosciences, Inc. was founded in 2001 and is headquartered in Basking Ridge, New Jersey.
|Regado Biosciences, Inc.’s ISS Governance QuickScore as of Apr 1, 2015 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 9; Compensation: 8.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Michael A. Metzger MBA,
Chief Exec. Officer, Pres, Chief Operating Officer and Director
|Dr. Christopher P. Rusconi Ph.D.,
Co-Founder, Chief Scientific Officer, Sr. VP of Discovery & Preclinical Devel. and Sec.
|Dr. Alexander R. Giaquinto Ph.D.,
Former Chief Compliance Officer
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|